A comprehensive view of Cancer. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Bayer opens new US$140M, 62,100 square-foot molecular oncology research, innovation center in Boston, Massachusetts, focused on developing targeted cancer therapies; center to enhance collaboration between Bayer, internal partners
Published:
July 01, 2022
by SeeNews Pharmaceuticals
|
McKesson and HCA Healthcare form JV combining McKesson’s US Oncology Research, HCA’s Sarah Cannon Research Institute to expand research, drug development, availability to clinical trials; McKesson also acquires Genospace personal medicine platform
Published:
July 01, 2022
by Business Wire
|
Eli Lilly partners with digital therapeutics firm Sidekick Health to launch integrated digital therapeutics solution in Germany to provide tailored treatment plan for breast cancer patients; other international markets for solution under consideration
Published:
June 30, 2022
by SeeNews Pharmaceuticals
|
Global gynecological cancer drug market projected to hit US$21.8B by 2030, with CAGR growth of 6.5% from 2021 to 2030; growth driven by increase in gynecological cancers, increased investment in cancer treatments; increased early screening
Published:
June 30, 2022
by PR Newswire
|
FDA grants Breakthrough Therapy Designation for Janssen’s talquetamab injectable antibody to treat relapsed or refractory multiple myeloma, a cancer of plasma cells; multiple myeloma affects 34,000 people in US annually, 176,000 worldwide
Published:
June 30, 2022
by PR Newswire
|
Ask us about our R&D/Patents market view
Trending Chart
Interactive chart with headline count